Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Experiments for a systematic comparison between stable-isotope-(deuterium) labeling and radio-((14)C) labeling for the elucidation of the in vitro metabolic pattern of pharmaceutical drugs.

Grunwald H, Hargreaves P, Gebhardt K, Klauer D, Serafyn A, Schmitt-Hoffmann A, Schleimer M, Schlotterbeck G, Wind M.

J Pharm Biomed Anal. 2013 Nov;85:138-44. doi: 10.1016/j.jpba.2013.07.004. Epub 2013 Jul 19.

PMID:
23933567
2.

Influence of food on the pharmacokinetics of oral alitretinoin (9-cis retinoic acid).

Schmitt-Hoffmann AH, Roos B, Sauer J, Schleimer M, Kovācs P, Stoeckel K, Maares J.

Clin Exp Dermatol. 2011 Apr;36 Suppl 2:18-23. doi: 10.1111/j.1365-2230.2011.04033.x.

PMID:
21443600
3.

Low levels of alitretinoin in seminal fluids after repeated oral doses in healthy men.

Schmitt-Hoffmann AH, Roos B, Sauer J, Brown T, Weidekamm E, Meyer I, Schleimer M, Maares J.

Clin Exp Dermatol. 2011 Apr;36 Suppl 2:12-7. doi: 10.1111/j.1365-2230.2011.04032.x.

PMID:
21443599
4.

Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.

Schmitt-Hoffmann AH, Roos B, Sauer J, Schleimer M, Schoetzau A, Leese PT, Weidekamm E, Maares J.

Clin Exp Dermatol. 2011 Apr;36 Suppl 2:4-11. doi: 10.1111/j.1365-2230.2011.04031.x.

PMID:
21443598
5.

Investigation of the species-dependent in vitro metabolism of BAL30630 by stable isotope labeling and isotope exchange experiments analyzed by capillary liquid chromatography coupled to mass spectrometry.

Wind M, Grunwald H, Gebhardt K, Illig K, Spickermann J, Nuoffer C, Roussel P, Klauer D, Fullhardt P, Schmitt-Hoffmann A, Schleimer M.

J Chromatogr A. 2009 May 1;1216(18):3946-53. doi: 10.1016/j.chroma.2009.03.022. Epub 2009 Mar 13.

PMID:
19327777
6.

Elucidation of the in vitro metabolic profile of stable isotope labeled BAL19403 by accurate mass capillary liquid chromatography/quadrupole time-of-flight mass spectrometry and isotope exchange.

Wind M, Gebhardt K, Grunwald H, Spickermann J, Donzelli M, Kellenberger L, Muller M, Fullhardt P, Schmitt-Hoffmann A, Schleimer M.

Rapid Commun Mass Spectrom. 2007;21(7):1093-9.

PMID:
17318924
7.

Investigation of low-abundant in vitro metabolites of stable isotope-labelled BAL4815 by accurate mass capillary-LC-ESI-qTof-MS and MS/MS.

Wind M, Spickermann J, Schleimer M, Donzelli M, Gebhardt K, Sturm-Haurany R, Klauer D, Fullhardt P, Schmitt-Hoffmann A.

J Mass Spectrom. 2006 Jul;41(7):903-10.

PMID:
16810647
9.

Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Schmitt-Hoffmann A, Nyman L, Roos B, Schleimer M, Sauer J, Nashed N, Brown T, Man A, Weidekamm E.

Antimicrob Agents Chemother. 2004 Jul;48(7):2576-80.

10.

Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Schmitt-Hoffmann A, Roos B, Schleimer M, Sauer J, Man A, Nashed N, Brown T, Perez A, Weidekamm E, Kovács P.

Antimicrob Agents Chemother. 2004 Jul;48(7):2570-5.

11.

Efficacy of BAL5788, a prodrug of cephalosporin BAL9141, in a mouse model of acute pneumococcal pneumonia.

Azoulay-Dupuis E, Bédos JP, Mohler J, Schmitt-Hoffmann A, Schleimer M, Shapiro S.

Antimicrob Agents Chemother. 2004 Apr;48(4):1105-11.

13.

Preformulation approaches to improve the oral bioavailability of two novel piperidine renin inhibitors in dog.

Bittner B, Chou R, Schleimer M, Morgenroth B, Zell M, Lavé T.

Arzneimittelforschung. 2002;52(8):593-9.

PMID:
12236046
14.

Piperidine renin inhibitors: from leads to drug candidates.

Märki HP, Binggeli A, Bittner B, Bohner-Lang V, Breu V, Bur D, Coassolo PH, Clozel JP, D'Arcy A, Doebeli H, Fischli W, Funk CH, Foricher J, Giller T, Grüninger F, Guenzi A, Güller R, Hartung T, Hirth G, Jenny CH, Kansy M, Klinkhammer U, Lave T, Lohri B, Luft FC, Mervaala EM, Müller DN, Müller M, Montavon F, Oefner CH, Qiu C, Reichel A, Sanwald-Ducray P, Scalone M, Schleimer M, Schmid R, Stadler H, Treiber A, Valdenaire O, Vieira E, Waldmeier P, Wiegand-Chou R, Wilhelm M, Wostl W, Zell M, Zell R.

Farmaco. 2001 Jan-Feb;56(1-2):21-7.

PMID:
11347960
15.

Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450.

Mountfield RJ, Senepin S, Schleimer M, Walter I, Bittner B.

Int J Pharm. 2000 Dec 15;211(1-2):89-92.

PMID:
11137342
16.

The effect of tolcapone on the pharmacokinetics of benserazide.

Jorga KM, Larsen JP, Beiske A, Schleimer M, Fotteler B, Schmitt M, Moe B.

Eur J Neurol. 1999 Mar;6(2):211-9.

PMID:
10053234
17.
18.

Orthodontic therapy: philosophy principals, and procedures.

Schleimer M.

Int J Orthod. 1970 Jun;8(2):49-76. No abstract available.

PMID:
4952714
19.

Retention, retainers and rhetoric.

Schleimer M.

Int J Orthod. 1966 Aug;4(3):4-12. No abstract available.

PMID:
5225726

Supplemental Content

Loading ...
Support Center